2,5-dihydroxybenzoic acid has been researched along with Cardiomyopathies, Primary in 1 studies
2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, N | 1 |
| Minatoguchi, S | 1 |
| Arai, M | 1 |
| Uno, Y | 1 |
| Nishida, Y | 1 |
| Hashimoto, K | 1 |
| Xue-Hai, C | 1 |
| Fukuda, K | 1 |
| Akao, S | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
1 other study available for 2,5-dihydroxybenzoic acid and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotonic Agents; Drug Combinations; Drugs, Chi | 2002 |